Startups
Proove Genomics is a precision medicine genetics laboratory and digital health company solving the dueling epidemics of opioid abuse and chronic pain, founded by Brian Meshkin. Proove Opioid Risk, Proove Pain Perception, and Proove Drug Metabolism combine genetic testing with clinical data to help clinicians make evidence-based prescribing decisions.
Overview
Location
United States, California, Irvine
Employees
201-500
Founded date
2009
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| It’s easy money: Lab offers doctors up to $144,000 a year to push dubious genetic tests, employees say | For doctors, the brochure from a California medical laboratory sounded like easy money: $30 for every person enrolled in a study of genetic tests meant to help select the best pain medication for each patient. A typical physician could make... |
Reviews 0
FAQ about Proove Genomics
When was Proove Genomics founded?
Proove Genomics was founded in 2009.
What has the press written about Proove Genomics?
Parsers VC has collected 2 articles mentioning Proove Genomics, among them “It’s easy money: Lab offers doctors up to $144,000 a year to push dubious genetic tests, employees say”.
Is Proove Genomics still active?
Proove Genomics is probably closed: its latest activity on Parsers VC dates from Dec 13, 2016.